FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression-Reference-Cited by-同舟云学术

FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression

Published:2016-04-25 Issue:23 Volume:7 Page:34617-34629
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wang Wei¹,Zhan Ming¹,Li Qi²,Chen Wei¹,Chu Huiling²,Huang Qihong³,Hou Zhaoyuan²,Man Mohan²,Wang Jian¹

Affiliation:

1. Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China

2. Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Institutes of Medical Sciences, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, China

3. The Wistar Institute, Philadelphia, PA 19104, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GW4064 inhibits migration and invasion through cathepsin B and MMP2 downregulation in human bladder cancer;Chemico-Biological Interactions;2024-02

2. Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy;International Journal of Molecular Sciences;2023-12-19

3. The Human Placental Amniotic Membrane Mesenchymal-Stromal-Cell-Derived Conditioned Medium Inhibits Growth and Promotes Apoptosis of Human Cholangiocarcinoma Cells In Vitro and In Vivo by Suppressing IL-6/JAK2/STAT3 Signaling;Cells;2023-12-07

4. FXR agonists for colorectal and liver cancers, as a stand-alone or in combination therapy;Biochemical Pharmacology;2023-06

5. Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies;American Journal of Clinical Oncology;2023-03-03